MassachusettsState Snapshot for Children

In this comparison, the NHQDR measures for Massachusetts for the most recent data year and the baseline year are compared to the average of all States.

Due to changes in methodology, including a transition from International Classification of Diseases, Ninth Revision (ICD-9) to Tenth Revision (ICD-10) codes and updates to the Quality Indicators software, the current measure set does not contain AHRQ Quality Indicator measure results based on Healthcare Cost and Utilization Project (HCUP) data. These changes to the measure set had a significant impact on overall meter scores, so they are not provided at this time. When data become available, State scores will again be included.

Measures Better Than Average in The Recent Year
Measure	Population	Recent Year	Recent Rate	Recent Performance	Baseline Year	Baseline Rate	Baseline Performance
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine	Total	2017	92.6	Better than Average	2000	87.7	Better than Average
Children ages 19-35 months who received 3 or more doses of polio vaccine	Total	2017	96.1	Better than Average	2000	94.1	Better than Average
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine	Total	2017	98.3	Better than Average	2000	96.1	Better than Average
Children ages 19-35 months who received 1 or more doses of varicella vaccine	Total	2017	97.6	Better than Average	2000	79.5	Better than Average
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine	Total	2017	94.9	Better than Average	2008	61.2	Better than Average
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine	Total	2017	92.5	Better than Average	2008	46.9	Average
Adolescent males ages 13-15 who received 3 or more doses of human papillomavirus (HPV) vaccine	Total	2017	45.1	Better than Average			Missing
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years	Total	2017	96.4	Better than Average	2008	49.8	Average
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years	Total	2017	95.8	Better than Average	2008	32.3	Average

Measures That Are Average in The Recent Year
Measure	Population	Recent Year	Recent Rate	Recent Performance	Baseline Year	Baseline Rate	Baseline Performance
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine	Total	2017	92.9	Average	2000	93.3	Better than Average
Infants born in the calendar year who received breastfeeding exclusively through 3 months	Total	2016	47.7	Average			Missing

National Healthcare Quality and Disparities Reports

MassachusettsState Snapshot for Children

Change Priority Populations